Fact CheckerSign in

NCT05193149Completed

Inspiratory Muscle Training in Obese Breast Cancer Survivors

Reducing Exercise Intolerance Through Inspiratory Muscle Training in Obese Breast Cancer

Source: ClinicalTrials.gov · Last updated 17 Aug 2026

Brief summary (registry, in English)

The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.

Status (registry)
Completed
Study type
Interventional
Enrollment
77 (actual)
First submitted
31 Dec 2021
Start date
13 Nov 2023
Primary completion date
27 Jul 2026
Lead sponsor
Ohio State University Comprehensive Cancer Center
Diseases
Obesity
NCT number
NCT05193149

What you commit to

  • Study type: Interventional
  • Participants enrolled: 77
  • From 13 Nov 2023 to the primary completion date, 27 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • metastatic breast cancer
  • ongoing or active infection with recent antibiotics or steroids
  • heart disease precluding exercise (congestive heart failure, unstable angina pectoris, cardiac arrhythmia)
  • psychiatric illness/social situations that would limit compliance with study requirements
  • orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise
  • any condition which in the investigator's opinion deems the subject an unsuitable candidate to participate in this study
  • presence of provokable ECG changes suggestive of heart disease, or dangerous arrhythmias or exercise induced hypertension, etc. during the cardiopulmonary exercise test

Other

  • functional limitations that make independent exercise unsafe
  • Bilateral Axillary lymph node dissection (ALND) of \>5 lymph nodes on each side, which could increase risk of lymphadenopathy with repeated blood pressure measurements during exercise or if patient has been advised by their clinician to avoid repeated BP measures on both arms. Bilateral Sentinel Lymph Node Biopsy (SLNB) will be allowed.
  • unwilling or unable to follow protocol requirements
  • pregnant or nursing
  • non-English speaking

Who the study is looking for

  • completed active treatment for a Stage 0-III breast cancer diagnosis within 6 months to 5 years of enrollment.
  • obese as defined by a body mass index (BMI) of 30 to 50 kg/m2
  • patients who are on adjuvant endocrine therapy will be allowed to participate.
  • sedentary (participating in less than 90 min of moderate intensity activity per week) and have at least one limitation in activity on the 10-question RAND-36 Physical Function Subscale to ensure some exercise intolerance

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Ohio State University
Coordinator of this site? Confirm its status
ColumbusUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.